SMAD5 and diabetes mellitus: Therefore, altering pHc or inhibiting the nuclear export of Smad5 may alleviate insulin deficiency, suggesting that Smad5 could serve as a potential therapeutic target for diabetes treatment (Fang et al. 2024).